E-ISSN: 2667-4610
Download Issue
Archives
Volume 12, Issue 2
June 2013
Back to Archives
Download Issue
Editorial
1
Review
16
Editorial
Editorial
Güven Aslan
Review
The importance of cellular androgenic hormonal mechanisms in treatment and progression of prostate cancer
Bertrand Tombal
Quick View
Is prostate cancer be screened according to Turkey data?
Rahmi Gökhan Ekin
Ferruh Zorlu
Quick View
Active surveillance in low risk prostate cancer
Ozan Bozkurt
Ömer Demir
Quick View
Treatment options in low-intermediate risk prostate cancer
Saadettin Yılmaz Eskiçorapçı
Deniz Bolat
Quick View
Radiotherapy in low and intermediate-risk prostate cancer
Deniz Yalman
Quick View
Robot-assisted radical prostatectomy: Operative technique — step by step
Bora Özveren
Levent Türkeri
Quick View
Surgical treatment and/or radiotherapy in high risk prostate cancer
Fatih Bıçaklıoğlu
Cenk Acar
Sinan Sözen
Quick View
Androgene suppression therapy in addition to radical radiotherapy in high risk prostate carcinoma
İlknur Bilkay Görken
Quick View
New treatment options for the castration resistant prostate cancer targeting the androgen synthesis and androgen receptor
Yavuz Selim Süral
Çağ Çal
Quick View
New treatment options in castration resistant prostate cancer: enzalutamide and abiraterone acetate
Bülent Akdoğan
Quick View
New treatment options for the castration resistant prostate cancer: Cabazitaxel and Spileucel-T
Gürbüz Görümlü
Erdem Göker
Quick View
New treatment options in castration resistant prostate cancer: denosumab, alpharadin
Hakan Gemalmaz
Quick View
Relationship between active surveillance / watchfull waiting and quality of life in localised prostate cancer
İlker Çelen
Yasin Ceylan
Quick View
How shoud PSA repalse (rising PSA) be managed after radical prostatectomy? How should treatment algorithms be shaped?
İlker Çelen
Murat Lekili
Quick View
Radical prostatectomy indications and outcomes in the high-risk localised prostate cancer
Hayrettin Şahin
Hasan Deliktaş
Quick View
Salvage radical prostatectomy for locally recurrent prostate cancer following primary radiotherapy
Ali Cansu Bozacı
Sertaç Yazıcı
Quick View
Reviewers
Review
Article
Reviewer
Corner
Authors
Submit
Article
Author
Corner
Journal Metrics
Clarivate Current Impact Factor: 0.1
Clarivate 5 Year Impact Factor: 0.1
Journal Information
Date of Foundation
Mar 2002
Abbreviation
Bull Urooncol
Last Issue
Editorial Board
Abstract in Index
Journal History
Forms
Permission Request Form
Copyright Agreement Form
Acknowledgements Form
Useful Links
ICMJE Recommendations
Crossref Similarity Check
ICMJE Conflict of Interest Disclosure Form
EndNote